Molecularly targeted therapy for malignant glioma

Jorge L Eller, Sharon L Longo, Michele M Kyle, Daniel Bassano, Daniel J Hicklin, Gregory W Canute, None, Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo. Neurosurgery. ,vol. 56, pp. 155- 162 ,(2005) , 10.1227/01.NEU.0000145865.25689.55

Ralf F. Pettersson, A. Jonas Ekstrand, C. David James, V. Peter Collins, V. Peter Collins, Barbara Seliger, Webster K. Cavenee, Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo Cancer Research. ,vol. 51, pp. 2164- 2172 ,(1991)

Michael Weaver, Douglas W. Laske, Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. Journal of Neuro-oncology. ,vol. 65, pp. 3- 13 ,(2003) , 10.1023/A:1026246500788

Ann C. Mladek, Brett L. Carlson, Jeffrey S. Eshleman, Jann N. Sarkaria, Brian D. Kastner, Kathleen L. Shide, Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy. Cancer Research. ,vol. 62, pp. 7291- 7297 ,(2002)

J. Sadones, C. Chaskis, E. J. Joosens, L. A. Dhondt, J. Baurain, P. In ’t Veld, A. Michotte, J. De Grève, B. Neyns, A stratified phase II study of cetuximab for the treatment of recurrent glioblastoma multiforme: Preliminary results Journal of Clinical Oncology. ,vol. 24, pp. 1558- 1558 ,(2006) , 10.1200/JCO.2006.24.18_SUPPL.1558

Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason, Kurt A. Jaeckle, Athanassios P. Kyritsis, Michael D. Prados, Victor A. Levin, W.K. Alfred Yung, Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials Journal of Clinical Oncology. ,vol. 17, pp. 2572- 2578 ,(1999) , 10.1200/JCO.1999.17.8.2572

Caroline Delmas, Christophe Heliez, Elizabeth Cohen-Jonathan, Dave End, Jacques Bonnet, Gilles Favre, Christine Toulas, Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation. International Journal of Cancer. ,vol. 100, pp. 43- 48 ,(2002) , 10.1002/IJC.10439

Caren V. Lund, Mai T. N. Nguyen, Geoffrey C. Owens, Andrew J. Pakchoian, Ashkaun Shaterian, Carol A. Kruse, Brian P. Eliceiri, Reduced Glioma Infiltration in Src-deficient Mice Journal of Neuro-oncology. ,vol. 78, pp. 19- 29 ,(2006) , 10.1007/S11060-005-9068-Y

J. Holash, S. Davis, N. Papadopoulos, S. D. Croll, L. Ho, M. Russell, P. Boland, R. Leidich, D. Hylton, E. Burova, E. Ioffe, T. Huang, C. Radziejewski, K. Bailey, J. P. Fandl, T. Daly, S. J. Wiegand, G. D. Yancopoulos, J. S. Rudge, VEGF-Trap: A VEGF blocker with potent antitumor effects Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 11393- 11398 ,(2002) , 10.1073/PNAS.172398299

Peter J. Houghton, Glen S. Germain, Franklin C. Harwood, John D. Schuetz, Clinton F. Stewart, Elisabeth Buchdunger, Peter Traxler, Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in Vitro Cancer Research. ,vol. 64, pp. 2333- 2337 ,(2004) , 10.1158/0008-5472.CAN-03-3344